Table 3 Relationship between expression of ISL1-S629-p and clinic pathological parameters of gastric cancer
Characteristic | Expression Level of ISL1-S629-p | p-value | |
|---|---|---|---|
++(%) | +++(%) | ||
(n = 29) | (n = 31) | ||
Age | |||
 ≤ 60 | 16 (55.2%) | 10 (32.3%) | 0.073 |
 > 60 | 13 (44.8%) | 21 (67.7%) | |
Gender | |||
 Male | 19 (65.5%) | 20 (64.5%) | 0.935 |
 Female | 10 (34.5%) | 11 (35.5%) | |
Depth of invasion | |||
 T1–2 | 12 (41.4%) | 22 (71.0%) | 0.021 |
 T3–4 | 17 (58.6%) | 9 (29.0%) | |
Lymph node metastasis | |||
 N0 | 10 (34.5%) | 15 (48.4%) | 0.275 |
 N1–3 | 19 (65.5%) | 16 (51.6%) | |
Distant metastasis | |||
 M0 | 25 (86.2%) | 28 (90.3%) | 0.702 |
 M1 | 4 (13.8%) | 3 (9.7%) | |
TNM stage | |||
 I | 7 (24.1%) | 14 (45.2%) | 0.309 |
 II | 10 (34.5%) | 7 (22.6%) | |
 III | 9 (31.0%) | 6 (19.4%) | |
 IV | 3 (10.3%) | 4 (12.9%) | |
Histological grade* | |||
 G1 | 1 (3.4%) | 2 (6.5%) | 0.010 |
 G2 | 6 (20.7%) | 16 (51.6%) | |
 G3 | 22 (75.9%) | 13 (41.9%) | |